What should I know first?

Risperidone is an antipsychotic medicine with actions at several receptors. This lesson focuses on dopamine D2 and serotonin 5-HT2 receptors using UK risperidone product information.

This is selected pharmacology, not a complete account of licensed indications, product forms or safety. Those questions belong to the separately checked UK medicine article.

This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.

How Brain Cells Communicate

Dopamine and serotonin carry messages between cells. Each has several receptor types. A receptor is a protein that responds to a messenger; the response depends on the receptor and the cell around it.

A messenger acts at a solid membrane receptor; protein coupling inside the cell illustrates a signaling response, rather than passage through an ion pore. Dopamine: A messenger can change signaling through its receptor. D2 receptor: This receptor symbol identifies a function, not a molecular structure. Cell response: The arrow represents a signaling response, not movement through a pore.
  1. Dopamine

    A messenger can change signaling through its receptor.

  2. D2 receptor

    This receptor symbol identifies a function, not a molecular structure.

  3. Cell response

    The arrow represents a signaling response, not movement through a pore.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Receptor icons are teaching symbols, not protein structures. No individual response or whole-brain blockade is implied.
About this illustration

A messenger can activate its receptor and change signalling in the receiving cell. Different receptors produce different effects.

How the Medication Changes Signalling

An antagonist interferes with a messenger’s activation of a receptor. Risperidone acts as an antagonist at dopamine D2 and serotonin type2 receptors. Its active metabolite, 9-hydroxyrisperidone, also contributes to its clinical effects.

Dopamine and serotonin act through different receptor systems. Antagonism does not mean that the medicine removes either messenger or blocks every signal everywhere.

A Closer Look at the Molecular Level

Known action: receptor antagonism is described in UK product pharmacology. Other receptors are affected as well, so this is a selected view.

Receptor binding is not a complete explanation of benefit, side effects or an individual’s experiences. The product information links pharmacological actions with proposed clinical effects; the diagram cannot test those explanations or predict a person’s response. No binding pose or affinity comparison is inferred.

Sources and References

  1. Risperidone 0.5 mg: UK SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  2. What Is a Neurotransmitter?

    Scope: International scientific education; not UK regulatory evidence.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top